{"transactions":[{"id":961096,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:13.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-124534","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124534/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985187,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-01T21:10:10.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-116673","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116673/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":1033838,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:20.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":825000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":825000,"source":{"system":"sec-edgar","filing":"0001213900-25-090611","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090611/ownership.xml","form_type":"4"}},{"id":1330935,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:05:22.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-24-109292","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109292/ownership.xml","form_type":"4"}},{"id":1369135,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:23.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-24-096891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000121390024096891/ownership.xml","form_type":"4"}},{"id":1419060,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-30T20:05:12.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 has been amended to correct the amount of option shares held by the Reporting Person."}],"balance_after":1400000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001213900-24-074517","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024074517/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-14"}},{"id":1433854,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:28:05.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":466667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":466667,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":466667},"source":{"system":"sec-edgar","filing":"0001213900-24-069249","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069249/ownership.xml","form_type":"4"}},{"id":1761202,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2023-10-12T16:15:35.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001013762-23-003534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000101376223003534/ownership.xml","form_type":"4"}},{"id":2141376,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2022-10-06T16:05:26.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-22-062472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000121390022062472/ownership.xml","form_type":"4"}},{"id":2543570,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2021-10-13T17:25:13.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-21-052671","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000121390021052671/ownership.xml","form_type":"4"}},{"id":3082853,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock) )","published_at":"2020-07-15T16:35:02.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares of the Company's common stock underlying the grant vest on the one-year anniversary of the Vesting Commencement Date, July 14, 2020, with the remainder vesting in 24 equal monthly installments thereafter, provided that the Optionee provides Continuous Service to the Company on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.19,"expiration_date":"2030-07-14","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-20-017558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000121390020017558/ownership.xml","form_type":"4"}}]}